id: antimicrobial_drug_exposure_to_acute_pancreatitis
name: Antimicrobial Drug Exposure â†’ Acute Pancreatitis
from_node:
  node_id: antimicrobial_drug_exposure
  node_name: Antimicrobial Drug Exposure
to_node:
  node_id: acute_pancreatitis
  node_name: Acute Pancreatitis
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Prescription and administration of antimicrobial drugs for infectious disease
  treatment'
- 'Step 2: Drug-induced biochemical or immunologic reactions affecting pancreatic
  tissue'
- 'Step 3: Activation of digestive enzymes within pancreatic tissue through drug-mediated
  mechanisms'
- 'Step 4: Development of acute pancreatic inflammation and clinical acute pancreatitis'
evidence:
  quality_rating: C
  n_studies: 51
  primary_citation: 'Angelo Del Gaudio et al. 2023. "Drug-Induced Acute Pancreatitis
    in Adults: Focus on Antimicrobial and Antiviral Drugs, a Narrative Review." *Antibiotics*.
    https://doi.org/10.3390/antibiotics12101495'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.174295'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: drug_type
  direction: strengthens
  strength: strong
  description: 'Specific antimicrobial drugs show stronger associations: didanosine,
    protease inhibitors, and metronidazole have the most evidence of correlation with
    acute pancreatitis compared to other antimicrobial agents'
- name: rechallenge_positive
  direction: strengthens
  strength: strong
  description: Positive rechallenge (recurrence of pancreatitis upon drug re-administration)
    strengthens causal inference for specific drug-pancreatitis associations
